Top

Published in:

01-10-2014 | Editorial

How nescience may obscure evidence

Authors: Prof. Dr. med. M.-L. Sautter-Bihl, F. Sedlmayer, W. Budach, J. Dunst, P. Feyer, R. Fietkau, W. Haase, W. Harms, M.D. Piroth, R. Souchon, F. Wenz, R. Sauer, Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO)

Published in: Strahlentherapie und Onkologie | Issue 10/2014

Excerpt

During the last decade, treatment trends for early breast cancer have been fluctuating between opposite extremes. More aggressive regional nodal irradiation (RNI) has been suggested by several recent studies [10, 17], on the other side, the previously unquestioned dogma of axillary dissection as an important part of breast cancer management was gradually abandoned in favor of sentinel node dissection (SLND). While consensus was rapidly achieved for pathologically negative SN, the management of patients with one or two positive SN remained controversial up to the first publication of a randomized study of the American College of Surgeons Oncology Group [3] which specifically addressed the outcome of such patients with ALND vs. none. Even though limitations of the study were recognized and let to some critical comments [7], current guidelines [8, 14] rapidly adopted the omission of ALND in these selected patients. …

Alço G, Iğdem S, Ercan T et al (2010) Coverage of axillary lymph nodes with high tangentlial fields in breast radiotherapy. Br J Radiol 83:1072–1076PubMedCrossRefPubMedCentral

Engel J, Emeny RT, Hölzel D (2012) Positive lymph nodes do not metastasize. Cancer Metastasis Rev. 31(1–2):235–246

Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569–575PubMedCrossRef

Haffty BG, Hunt KK, Harris JR et al (2011) Positive sentinel nodes without axillary dissection: implications for the radiation oncologist. J Clin Oncol 29:4479–4481PubMedCrossRef

Jagsi R, Chadha M, Moni J et al (2014) Radiation field design in the ACOSOG Z0011 (Alliance). Trial J Clin Oncol 32

Lupe K, Truong PT, Alexander C et al (2011) Ten-Year locoregional recurrence risks in women with nodal micrometastatic breast cancer staged with axillary dissection. Int J Radiat Oncol Biol Phys 81:e681–e688PubMedCrossRef

Murthy V, Ballehaninna UK, Chamberlain RS (2014) Unanswered questions about the role of axillary dissection in women with invasive breast cancer and sentinel node metastasis. Clin Breast Cancer 12:305–307CrossRef

NCCN. Clinical practice guidelines in oncology: breast cancer, version 1.2014. National Comprehensive Cancer Network, www.nccn.org

Pepels MJ, de Boer M, Bult P et al (2012) Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells. Ann Surg 255:116–121PubMedCrossRef

10.

Poortmans P, Kirkove C, Budach V et al (2013) Irradiation of the internal mammary and medial supraclavicular lymph nodes in stage I to III breast cancer: 10 years results of the EORTC Radiation Oncology and Breast Cancer Groups phase III trial 22922/10925. EJC 49(Suppl 3)1 (abstract BA2)

11.

Reznik J, Cicchetti MG, Degaspe B et al (2005) Analysis of axillary coverage during tangential radiation therapy to the breast. Int J Radiat Oncol Biol Phys 61:163–168PubMedCrossRef

12.

Rutgers EJ, Donker M, Straver ME et al (2013) Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: final analysis of the EORTC AMAROS trial (10981/22023. J Clin Oncol 31 (Abstract LBA1001)

13.

Sautter-Bihl ML, Sedlmayer F, Budach W et al (2014) Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). DEGRO practical guidelines: radiotherapy of breast cancer III–radiotherapy of the lymphatic pathways. Strahlenther Onkol 190(4):342–351PubMedCrossRef

14.

S3. Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms, Langversion 3.0, Aktualisierung 2012, AWMF-Register-Nummer: 032-045OL 2012

15.

Schlembach PJ, Buchholz TA, Ross MI et al (2001) Relationship of sentinel and axillary level I–II lymph nodes to tangential fields used in breast irradiation. Int J Radiat Oncol Biol Phys 51:671–678PubMedCrossRef

16.

Weaver DL, Ashikaga T, Krag DN et al (2011) Effect of occult metastases on survival in node-negative breast cancer. N Engl J Med 364:412–421PubMedCrossRefPubMedCentral

17.

Whelan T, Olivotto I, Ackerman I et al (2011) NCIC-CTG MA. 20: an intergroup trial of regional nodal irradiation in early breast cancer. J Clin Oncol 29(suppl) (abstract LBA 1003)

Title: How nescience may obscure evidence
Authors: Prof. Dr. med. M.-L. Sautter-Bihl
F. Sedlmayer
W. Budach
J. Dunst
P. Feyer
R. Fietkau
W. Haase
W. Harms
M.D. Piroth
R. Souchon
F. Wenz
R. Sauer
Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO)
Publication date: 01-10-2014
Publisher: Springer Berlin Heidelberg
Published in: Strahlentherapie und Onkologie / Issue 10/2014
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-014-0755-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

How nescience may obscure evidence

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 10/2014

Postoperative Bestrahlung von Thoraxwand und Lymphabflusswegen nach Mastektomie bei Patientinnen mit bis zu 3 befallenen axillären Lymphknoten

Limb-sparing management with surgical resection, external-beam and intraoperative electron-beam radiation therapy boost for patients with primary soft tissue sarcoma of the extremity

Commentary on “Late bone and soft tissue sequelae of childhood radiotherapy”

FET-PET-based reirradiation and chloroquine in patients with recurrent glioblastoma

Simultaneous integrated boost-intensity modulated radiation therapy for inoperable hepatocellular carcinoma

Professor Dr. Fridtjof Nüsslin zum 75. Geburtstag